UBS Reiterates Buy Rating on QNT, Sets Target at $93
UBS analyst David Vogt maintains a Buy rating on QNT with a price target of $93, a 13.78% upside from the current price.
Key Points
- UBS reiterated its Buy rating on QNT, setting a price target of $93 as of June 29, 2026.
- UBS's $93 price target implies 13.78% upside from Quantinuum Inc.'s ($QNT) current $81.74 share price.
- Shares of QNT traded at $75.57 on Monday, with multiple analysts initiating Buy ratings and targets ranging from $90 to $155.
- Insiders, including CFO Nitesh Sharan, bought shares in early June at $60 each.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 29, 2026, UBS analyst David Vogt reiterated his Buy rating on QNT, setting a price target of $93. This reaffirmation comes as QNT shares traded around $75.57 on Monday.
UBS vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Analysts Set New Price Targets
On June 29, 2026, UBS initiated coverage on QNT with a Buy rating and a $93 price target. JP Morgan also started coverage with a Buy rating and a $97 target. Jefferies, Cantor Fitzgerald, and Mizuho each initiated with Buy ratings, setting price targets at $90. Meanwhile, Craig-Hallum and Evercore ISI Group offered Buy ratings with targets of $100 and $98, respectively. Notably, Rosenblatt set a higher target of $155, also with a Buy rating.
Insider Buying and Selling at Quantinuum Inc.
In early June, several insiders bought shares of QNT. On June 5, 2026, Michal Stepniak purchased 13,333 shares, while Joseph Jimenez acquired 66,665 shares, both at $60 each. Vimal Kapur and Eric Branderiz also bought 13,000 and 8,334 shares, respectively, at the same price. Additionally, Prineha Narang and Chief Financial Officer Nitesh Sharan bought 200 and 6,500 shares, respectively, each transaction occurring at $60 per share.
Bottom Line
UBS's reiteration of a Buy rating on QNT with a $93 target reflects continued confidence in the stock's potential. Multiple analysts have initiated coverage with Buy ratings, suggesting broad optimism. Insider buying in early June further indicates positive sentiment from within the company. As always, investors should note that analyst ratings are forward-looking and reflect expectations that may not materialize.
Get Quantinuum Inc. alerts
New 13F filings, insider trades, and analyst moves on $QNT, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.